The Trump Administration has ended a prominent HIV vaccine development program led by Duke University researchers, a move that school said “represents an enormous setback” for creating a vaccine to fight the cause of AIDS. Researchers were notified on Friday that the Department of Health and Human Services would not renew two National Institutes of Health grant, totaling $258 million, for the Duke Human Vaccine Institute and the Scripps Research Institute to operate the Center for HIV/AIDS Vaccine Development. Matt Martin, the Associated Director of the North Carolina Aids Action Network, joined Jeff Hamlin to discuss the fallout of the Trump Administration’s move.